← Back to Search

Cell Therapy

Antria Cell Preparation Process for Chronic Wounds

Phase 1
Waitlist Available
Led By Leonard E Maliver, MD
Research Sponsored by Antria
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Able to understand and provide written and verbal informed consent
Female or Male, Age 18 years or older
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 1 year
Awards & highlights

Study Summary

This trial is testing a new way to treat chronic wounds using a person's own fat cells. The goal is to show it is safe and effective.

Eligible Conditions
  • Chronic Wounds

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1 year
This trial's timeline: 3 weeks for screening, Varies for treatment, and 1 year for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Bates-Jensen Wound Assessment
Secondary outcome measures
Digital Picture of wound

Trial Design

1Treatment groups
Experimental Treatment
Group I: Antria Cell Preparation ProcessExperimental Treatment1 Intervention
Safety will be evaluated by collection of vital signs, EKG, patient surveys, and assessments

Find a Location

Logistics

Participation is compensated

You will be compensated for participating in this trial.

Who is running the clinical trial?

AntriaLead Sponsor
3 Previous Clinical Trials
44 Total Patients Enrolled
Leonard E Maliver, MDPrincipal InvestigatorAntria Inc.

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
~5 spots leftby Mar 2025